MedPath

HSA Approvals

Singapore Health Sciences Authority approved drug registrations and therapeutic product information

Health Sciences Authority
Singapore
5,858 Approvals
Showing 881 to 900 of 5,858 approvalsPage 45 of 293

SLINDA FILM-COATED TABLETS 4MG

Approval Number: SIN16354P
Approval: Nov 1, 2021

DAGPORT PROLONGED RELEASE HARD CAPSULES 1MG

Approval Number: SIN16356P
Approval: Nov 1, 2021

DAGPORT PROLONGED RELEASE HARD CAPSULES 5MG

Approval Number: SIN16355P
Approval: Nov 1, 2021

TABRECTA FILM-COATED TABLET 200mg

Approval Number: SIN16351P
Approval: Oct 22, 2021

TABRECTA FILM-COATED TABLET 150mg

Approval Number: SIN16350P
Approval: Oct 22, 2021

EVRYSDI POWDER FOR ORAL SOLUTION 0.75 MG/ML

Approval Number: SIN16349P
Approval: Oct 20, 2021

LATUDA TABLET 20MG

Approval Number: SIN16346P
Approval: Oct 12, 2021

FLONOXIN FILM-COATED TABLET 400MG

Approval Number: SIN16347P
Approval: Oct 12, 2021

VERQUVO FILM-COATED TABLET 2.5MG

Approval Number: SIN16343P
Approval: Oct 1, 2021

VERQUVO FILM-COATED TABLET 10MG

Approval Number: SIN16340P
Approval: Oct 1, 2021

VERQUVO FILM-COATED TABLET 5MG

Approval Number: SIN16342P
Approval: Oct 1, 2021

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.